However, previous study documented that the use of TNF-antagonists and DMARDs may decrease the risk of CAD [31, 32] Thus, we applied a Cox Proportional Hazards Model by controlling for the available potential confounding factors of CAD, including age, gender, comorbidities and medication, to make the two groups comparable. The gene discussed is TNF; the disease is coronary artery disorder.